Efficacy and safety of CAR-T cell therapy in minorities

被引:0
|
作者
Thakkar, Astha [1 ]
Abreu, Michelly [1 ]
Pradhan, Kith [2 ]
Sica, R. Alejandro [1 ]
Shastri, Aditi [1 ]
Kornblum, Noah [1 ]
Shah, Nishi [1 ]
Mantzaris, Ioannis [1 ]
Gritsman, Kira [1 ]
Feldman, Eric [1 ]
Elkind, Richard [1 ]
Green-Lorenzen, Susan [3 ]
Verma, Amit [1 ]
Braunschweig, Ira [1 ]
Goldfinger, Mendel [1 ]
机构
[1] Blood Canc Inst, Montefiore Einstein Canc Ctr, Montefiore Med Ctr, Dept Oncol, New York, NY USA
[2] Albert Einstein Coll Med, Dept Epidmiol & Populat Hlth, New York, NY USA
[3] Montefiore Hlth Syst, New York, NY USA
关键词
DISPARITIES; LYMPHOMA;
D O I
10.1038/s41409-022-01670-1
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:1187 / 1190
页数:4
相关论文
共 50 条
  • [31] CAR-T Cell Therapy for T-Cell Malignancies
    Testa, Ugo
    Chiusolo, Patrizia
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [32] Possible Factors on Efficacy and Safety of CAR-T Therapy in Relapsed or Refractory Aggressive B-Cell Lymphoma
    Huang, Haiwen
    Jiang, Yibin
    Jin, Zhengming
    Li, Caixia
    Wu, Depei
    BLOOD, 2018, 132
  • [33] A novel switchable car-T cell therapy for tumor retargeting and improved safety
    Castellarin, M.
    Sands, C.
    Young, R.
    June, C.
    CYTOTHERAPY, 2020, 22 (05) : S18 - S19
  • [34] Monitoring and safety of CAR-T therapy in clinical practice
    Serra Lopez-Matencio, Jose M.
    Garcia de Soria, Valle Gomez
    Gomez, Manuel
    Alanon-Plaza, Estefania
    Munoz-Calleja, Cecilia
    Castaneda, Santos
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (03) : 363 - 371
  • [35] Liquid biopsy approach to monitor the efficacy and response to CAR-T cell therapy
    Shishido, Stephanie N.
    Hart, Olivia
    Jeong, Sujin
    Moriarty, Aidan
    Heeke, Darren
    Rossi, John
    Bot, Adrian
    Kuhn, Peter
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (02)
  • [36] In-depth analysis of the safety of CAR-T cell therapy for solid tumors
    Dong, Jiayi
    Wu, Jiexiong
    Jin, Ye
    Zheng, Zhu
    Su, Ting
    Shao, Lijuan
    Bei, Jiaxin
    Chen, Size
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [37] A SNIPpet of safety: a Goldilocks approach in CAR-T therapy
    Mehdi Benzaoui
    Naomi Taylor
    Nirali N. Shah
    Cell Research, 2022, 32 : 603 - 604
  • [38] Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy
    Li, Xin
    Liu, Mei-Jing
    Mou, Nan
    Yang, Zhen-Xing
    Wang, Jia
    Mu, Juan
    Zhu, Hai-Bo
    Deng, Qi
    ONCOLOGY LETTERS, 2021, 22 (05)
  • [39] A SNIPpet of safety: a Goldilocks approach in CAR-T therapy
    Benzaoui, Mehdi
    Taylor, Naomi
    Shah, Nirali N.
    CELL RESEARCH, 2022, 32 (07) : 603 - 604
  • [40] Teaming up for CAR-T cell therapy
    Waesch, Ralph
    Munder, Markus
    Marks, Reinhard
    HAEMATOLOGICA, 2019, 104 (12) : 2335 - 2336